English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech BioTech (Sci&Research)
药研实力获认可 翰森制药主力拓创新药研发
May 31, 2019 12:36 HKT
藥研實力獲認可 翰森製藥主力拓創新藥研發
May 31, 2019 12:34 HKT
中国生物制药公布2019年第一季度业绩
May 22, 2019 10:42 HKT
中國生物製藥公佈2019年第一季度業績
May 22, 2019 10:41 HKT
Sino Biopharmaceutical Announces 2019 First Quarterly Results
May 22, 2019 10:40 HKT
Three HKTDC initiatives boost local start-up ecosystem
May 21, 2019 15:00 HKT
Local biotech start-ups begin to target mass market
May 17, 2019 17:00 HKT
TRIGR Therapeutics Announces Formation of Global Clinical & Scientific Advisory Board
May 13, 2019 17:00 HKT
TRIGR Therapeutics Announces Formation of Global Clinical & Scientific Advisory Board
May 13, 2019 17:00 HKT
HKTDC Hong Kong International Medical and Healthcare Fair opens next Tuesday
May 09, 2019 18:00 HKT
Captiva Verde Acquires Licensed Applicant of Hand Crafted Outdoor Organic High Potency Cannabis Production and Processing in Canada
May 09, 2019 15:00 HKT
Dyadic攜手印度血清研究所 Serum研發和製造 全球廣泛使用且可負擔得起的抗體產品和疫苗
May 09, 2019 12:00 HKT
Dyadic携手印度血清研究所 Serum研发和制造 全球广泛使用且可负担得起的抗体产品和疫苗
May 09, 2019 12:00 HKT
Dyadic and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products and Vaccines
May 09, 2019 12:00 HKT
Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER
Apr 26, 2019 13:30 HKT
维亚生物宣布于港交所主板上市计划
Apr 25, 2019 15:37 HKT
維亞生物宣佈於港交所主板上市計劃
Apr 25, 2019 15:36 HKT
Viva Biotech Announces Proposed Listing on the Main Board of SEHK
Apr 25, 2019 15:35 HKT
Hemp, Inc. Releases 2018 Annual Report Showing Substantial Revenue Increase Over Previous Year
Apr 22, 2019 09:00 HKT
Hemp, Inc. Reports Oklahoma Next to Allow Commercial Production of Industrial Hemp
Apr 19, 2019 01:00 HKT
<< Previous  Next >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: